Evidence map›Paper›PMID 34807473›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2022

Lack of association between seborrheic dermatitis and SARS-CoV-2 outcomes.

U Rakita, T Kaundinya, A Guraya, K Nelson, B Maner, J Manjunath, G Schwartzman, B Lane, J I Silverberg

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

U RakitaChicago Medical School, Rosalind Franklin University, North Chicago, IL, USA.ORCID https://orcid.org/0000-0002-8447-4283
T KaundinyaNorthwestern Feinberg School of Medicine, Chicago, IL, USA.ORCID https://orcid.org/0000-0002-0680-0522
A GurayaMidwestern University Chicago College of Osteopathic Medicine, Downers Grove, IL, USA.ORCID https://orcid.org/0000-0003-1876-3586
K NelsonDepartment of Dermatology, George Washington School of Medicine, Washington, DC, USA.
B ManerRoss University School of Medicine, St. Michael, Barbados.
J ManjunathDepartment of Dermatology, George Washington School of Medicine, Washington, DC, USA.ORCID https://orcid.org/0000-0002-4455-4764
G SchwartzmanDepartment of Dermatology, George Washington School of Medicine, Washington, DC, USA.
B LaneMichigan State University College of Human Medicine, East Lansing, MI, USA.
J I SilverbergDepartment of Dermatology, George Washington School of Medicine, Washington, DC, USA.ORCID https://orcid.org/0000-0003-3686-7805
George Washington University · USMichigan State University · USMidwestern University · USNorthwestern University · USRosalind Franklin University of Medicine and Science · USRoss University School of Medicine · BB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Dermatitis, SeborrheicMalasseziaAntifungal AgentsHumansSARS-CoV-2Antifungal Agents

Identifiers

PMID34807473
PMCPMC9011498
OpenAlexW3216708248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.